At a glance

Our pivotal position in the rapidly evolving regenerative medicine field is supported by a group of leading investors. Through the significant funding we have raised and the continual development of our pipeline of novel tissue-specific cellular medicines, we are well positioned to push the frontiers of science and innovation in regenerative medicine.

Investor Enquiries

For investor enquiries please contact:

Twitter Feed